andrew kuykendall on polycythemia vera - medpage today
Published 3 years ago • 86 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
9:15
andrew kuykendall, md, on symptom improvement outcomes with rusfertide in polycythemia vera
-
5:10
thromboembolic events in patients with polycythemia vera
-
1:27
dr. kuykendall on choosing ruxolitinib or fedratinib in myelofibrosis
-
4:23
updated phase 2 data shows promise for efficacy of polycythemia vera treatment
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
3:12
diagnosed early in life with polycythemia vera: todd’s mpn story
-
12:06
can patients with polycythemia vera (pv) live a normal lifespan?
-
1:31
dr. kuykendall on toxicity profiles of ruxolitinib and fedratinib in myelofibrosis
-
2:16
the current state-of-the-art in mf and pv therapy and future outlooks
-
4:59
behind the mystery, polycythemia vera
-
1:29
treatment options for polycythemia vera
-
1:49
dr. kuykendall on the impact of ruxolitinib in myeloproliferative neoplasms
-
2:10
aacr 2021 - dr. andrew kuykendall - abstract ct236
-
3:07
the current treatment algorithm for polycythemia vera
-
1:04
wcpos v 2024: day 2 highlights
-
1:39
upcoming agents in et and pv
-
55:33
mpn boston patient and caregiver event 2022: dr. andrew kuykendall
-
2:55
interferons and myeloproliferative neoplasms (mpns)
-
0:31
change the way you see polycythemia vera ‐ takeactionpv
-
7:34
behind the mystery: living with polycythemia vera
-
1:27
insights into the reveal trial: the efficacy of ruxolitinib for the treatment of patients with pv